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Abstract 
 
 Two Chinese patients with mild and moderate hemoglobin (Hb) H disease were 
investigated for rare mutations in the α-globin genes (HBA1, HBA2) in addition to 
--(SEA) deletion. One patient was a 41-year old man with mild anemia (Hb 11.3 g/dl). 
Multiplex ligation-dependent probe amplification (MLPA) revealed a rare 2392-base 
deletion involving the entire HBA1. Mapping by gap-polymerase chain reaction (PCR) 
defined the exact breakpoints of this deletion (HBA1:g36859_39252del2392) and 
confirmed its identity with a recently reported HBA1 deletion found in Southern 
Chinese. The other patient was a 53-year old man with moderate anemia (Hb 9.5 g/dl). 
Automated direct nucleotide sequencing identified a novel single nucleotide deletion 
at codon 40 of HBA2 (HBA2:c123delG). This leads to a frameshift which modifies 
the C-terminal sequence to (40)Lys-Pro-Thr-Ser-Arg-Thr-Ser-Thr(47)COOH and the 
introduction of a stop codon TGA 23 nucleotides downstream. These two cases 
demonstrate the power of MLPA and direct nucleotide sequencing to detect and 
characterize rare and novel mutations. They also highlight the differential effect of 
HBA1 and HBA2 gene mutation on α thalassemia phenotype due to their different 
transcriptional activity. 
   
  
 Hemoglobin H disease is typically caused by deletion of both HBA1 and HBA2 
on one chromosome 16 and either a complete deletion or a point mutation in HBA1 or 
HBA2 on the other homologue. This results in the deletional and non-deletional form 
of Hb H disease, respectively. In the southern Chinese population, the overwhelming 
majority of the two-gene deletion in cis is --(SEA). Single-gene deletions -alpha(4.2) 
or -alpha(3.7) are found in deletional Hb H disease, while Hb Constant Spring (CS), 
Hb Quong Sze (QS) and codon 30 (ΔGAG) deletion predominate in the 
non-deletional form. More than 90% of Hb H disease can therefore be genotyped by a 
simple multiplex gap-PCR and allele-specific PCR priming approach targeted at these 
common mutations (1). In rare instances, these routine techniques fail to reveal the 
complete α-globin genotype and more empirical genotyping methods are indicated. 
We describe here the detection of two rare mutations in two patients with Hb H 
disease. 
 Patient A was a 53-year old Chinese man with Hb 9.5 g/dL, mean corpuscular 
volume (MCV) 74.7 fL, mean corpuscular Hb (MCH) 19.3 pg and red cell 
distribution width (RDW) 21.6%. Supravital staining with brilliant cresyl blue showed 
98% of red cells bearing Hb H inclusion bodies. Patient B was a 41-year old Chinese 
man with Hb 11.3 g/dL, MCV 73.2 fL, MCH 20.4 pg and RDW 22.4%. Hemoglobin 
H inclusion bodies were seen in 90% of red cells. Routine α-globin genotyping only 
detected heterozygous --(SEA) in both patients. Rare or novel mutations were 
suspected and automated direct nucleotide sequencing of HBA1 and HBA2 was 
performed as previously described (1). In Patient A, a hemizygous novel single 
nucleotide deletion was found in codon 40 of HBA2 (AAG to AA-; HBA2:c123delG), 
which causes a frameshift and creates a new TGA stop codon 23 nucleotide 
downstream (Figure 1). This predicts the production of a truncated polypeptide 
47-amino acid in length with a carboxyl end Lys-Pro-Thr-Ser-Arg-Thr-Ser-Thr. 
However, the mutated mRNA is more likely to undergo nonsense-mediated decay 
without significant translation. No functional globin chain production is therefore 
expected from this novel mutation. HBB sequencing results were normal. 
 No sequence variation was detected in Patient B by Sanger sequencing of HBA1, 
HBA2 and HBB. An unusual large deletion of HBA1 or HBA2 was suspected. Alpha 
MLPA was performed to screen for deletion in the α-globin gene cluster. Probes and 
reaction mixture for ligation and PCR were purchased from MRC-Holland (SALSA 
MLPA kit P140-B3 HBA, MRC-Holland, Amsterdam, the Netherlands). Testing and 
data analysis procedures were done as previously described (2). Apart from the 
heterozygous loss of probe products contributed by --(SEA), which spans from the 
probe binding site between pseudogenes HBA2P and HBA1P to the probe binding site 
3.7 kb downstream of HBA1, there was further loss of products of all probes targeting 
from exon 1 of HBA1 to a site 0.5 kb downstream of HBA1. This suggests a deletion 
of the entire HBA1 in addition to --(SEA) (Figure 2). The exact breakpoints were 
mapped by a gap-PCR using the MLPA probes flanking the putative HBA1 deleted 
region (alpha MLPA 256 nucleotide probe as forward primer: 5' 
TTCTCTGCCCAAGGCAGCTTACCC 3'; alpha MLPA 310 nucleotide probe as 
reverse primer: 5' AGGTGTTTCTTCAGGGCAGTGAAC 3'). A 2.2-kb PCR product 
was obtained (Figure 3). Direct nucleotide sequencing of this PCR product identified 
the 5' breakpoint at nucleotide 36859 of NG_000006.1 GenBank reference sequence, 
which is 684 bp upstream of the start point of HBA1 whereas the 3' breakpoint lies at 
nucleotide 39252, which is 867 bp downstream of the end of HBA1. Due to sequence 
micro-homology flanking the breakpoints, alternative breakpoints at nucleotide 36853 
and nucleotide 39245 can also generate the same deletion (Figure 4). Results 
confirmed the presence of a 2392-base deletion of HBA1. A search of the literature 
revealed three reports of this HBA1 deletion in Chinese (3-5). Simple heterozygotes 
are reported to have a very mild phenotype, which is consistent with a lesser 
contribution to globin production by HBA1 compared with HBA2. The mild deletional 
Hb H disease phenotype observed in our patient is also consistent with this. Notably, 
all three previously reported Hb H disease patients of this same genotype (compound 
heterozygous for –SEA and 2.4 kb HBA1 deletion) had moderate disease severity with 
Hb ranging from 8.3 to 9 g/dL. One of them was a teenage female with a very low 
MCV of 58 fL; the other was a pregnant woman, and the age and clinical details of 
the remaining patient were not stated. Other contributing factors of Hb level such as 
age, sex, iron status, physiological hemodilution and concurrent diseases might have 
affected the phenotype. 
 These two cases demonstrate the power of direct nucleotide sequencing and 
MLPA in the detection and characterization of novel and rare thalassemic mutations. 
Moreover, they illustrate clearly the phenotypic difference between HBA1 and HBA2 
mutations in the setting of Hb H disease. Finally, the study confirms independently 
the occurrence of the rare and mild 2.4-kb HBA1 deletion in Southern Chinese.  
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Figure Legends 
 
FIGURE 1 Partial chromatogram showing a hemizygous HBA2 sequence tracing 
in Patient A. A guanine deletion at codon 40 leads to shifting of reading frame and 
generation of a new TGA stop codon 23 bases downstream (underlined).   
 
 
 
 
 
 
 FIGURE 2 Multiplex ligation-dependent probe amplification analysis in Patient B 
showing a probe signal loss pattern consistent with compound heterozygous --(SEA) 
and HBA1 deletion. Note that probe products targeting exon 1 of HBA1 and HBA2 are 
identical and probe products targeting exon 3 of these two genes are identical. A 
normalized signal ratio of 0.25 for these probes in this case is consistent with a 
deletion of either HBA1 or HBA2 in addition to --(SEA).  
 
 
 
 
 FIGURE 3 Schematic diagram showing the two gap-polymerase chain reaction 
primer sites (arrows). The rare HBA1 deletion in Patient B removes 2392 bases (white 
bar) and allows the generation of a 2.2-kb amplified fragment (black bar) by the 
primer pair. 
 
FIGURE 4 Partial chromatogram showing a hemizygous HBA1 sequence tracing 
in Patient B. The same six nucleotide TGAATC sequence flanking the breakpoints 
(underlined) is present at nucleotide 36854 to 36859 and nucleotide 39246 to 39251. 
This sequence micro-homology may have facilitated interchromosomal or 
intrachromosomal misalignment and unequal crossing-over. Breaking and rejoining at 
either end of this short sequence will generate the same deletion. 
